SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senomys(SNMX)- A Taste for Success!!! -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (12)3/28/2005 9:44:20 AM
From: im a survivor  Respond to of 192
 
<<and what I think is a most conservative revenue basis you could see (SNMX) earning $1.70 a share within the next couple of years>>

In their most recent filings they state they expect to continue to see losses for at least 2 more years. Are they being conservative? Could profits come in sooner? What if it takes longer then 2 years....I notice in their statement they didnt say WITHIN 2 years, they said for at least 2 years, giving me the impression they are not that close to profitability. I really like this sector....Lots of companies are going to be looking for healthier alternatives so this could be very big....I am just having a very tough time geting a handle on why this stocks chart looks so good, but the numbers dont and they flat out say they dont expect to be profitable for at least 2 years....most investors are not that patient...yes, we look forward as we should...but most when they see " we will continue to incurr losses for at least 2 more years", typically stay away....yet this stock has a very nice looking chart....what am I missing here?